Companies
- Companies
- Browse
Companies
The Brazilian affiliate of ALTANA Pharma AG More
Morphochem discovers and develops highly selective small molecule compounds for the medicines of tomorrow More
CellMed is focusing on its Long Term Biological Drug Delivery of Therapeutic Proteins based on its proprietary, innovative and broadly applicable encapsulation concept for cells and tissue. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 19 pages - $99
North Eastern Germany Society of Gynaecologic Oncology – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 29 pages - $500
Jan 2011 - 124 pages - $1,740
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Aug 2010 - 87 pages - $2,500
Dec 2006 - 90 pages - $995
Jun 2009 - 110 pages - $1,040
Nov 2010 - 428 pages - $2,695
Nov 2010 - 26 pages - $125
Your selection
Browse By
- Industry sector
- Intravesical
- Nasal
- Nasal topical
- Ophthalmic
- Oral liquid
- Oral solid
- Otic
- Parenteral
- Pulmonary
- Rectal
- Systemic
- Topical
- Vaginal
- Therapeutic target
- Anti-oxidant
- Bladder cancer
- Bone cancer
- Brain cancer
- Breast cancer
- Cancer (other)
- Cancer side effects
- Cervical cancer
- Colorectal cancer
- Head and neck cancer
- Kaposi's sarcoma
- Kidney cancer
- Leukemia
- Liver cancer
- Lung cancer
- Lymphoma
- Ovarian cancer
- Pancreatic cancer
- Polyps
- Prostate cancer
- Skin cancer
- Stomach/Esophageal
- Testicular cancer
- Transplant
- Treatments
- Tumor (other)
- Vaginal Cancer
- Womb cancer
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us